Progression rates according to presence or absence of ACAs at diagnostic cytogenetics
| Group . | No progression . | Progression . | Percentage progressing . | P . |
|---|---|---|---|---|
| Original major route lesion | ||||
| Yes | 14 | 3 | 17.6 | .011 |
| No | 727 | 19 | 2.5 | |
| Additional lesions | ||||
| Yes | 9 | 5 | 35.7 | <.001 |
| No | 732 | 17 | 2.3 | |
| Combined group | ||||
| Yes | 21 | 6 | 22.2 | <.001 |
| No | 720 | 16 | 2.2 |
| Group . | No progression . | Progression . | Percentage progressing . | P . |
|---|---|---|---|---|
| Original major route lesion | ||||
| Yes | 14 | 3 | 17.6 | .011 |
| No | 727 | 19 | 2.5 | |
| Additional lesions | ||||
| Yes | 9 | 5 | 35.7 | <.001 |
| No | 732 | 17 | 2.3 | |
| Combined group | ||||
| Yes | 21 | 6 | 22.2 | <.001 |
| No | 720 | 16 | 2.2 |
Original major route and additional lesions groups are as defined in Table 1 and the text. The combined group comprises patients with ≥1 of any of the 9 lesions in either the original major route or the additional lesions group. P values were evaluated by Fisher’s exact test.